Delivery Order SPE2DB20D2014-SPE2DB26FA13L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency has awarded a delivery order valued at $1,690.71 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count bottles). This competitive, non-set-aside award was made on August 7, 2025, with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $7,779.01 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 20, 2025, issued on October 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,501.99. This competitive, non-set-aside award was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.12 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100 count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitive, non-set-aside award utilizes firm fixed pricing under a delivery order contract type. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $1,212.48. Issued on September 16, 2025, this firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $1,696.06. This firm fixed-price delivery order, with an ultimate completion date of April 22, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,755.26. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure with an ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count units) valued at $2,150.67, with completion required by June 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate facility in Conshohocken, Pennsylvania....
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA13LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $4,382.80. This competitively awarded, firm fixed-price delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military healthcare programs and other government systems worldwide. The indefinite delivery vehicle enables flexible procurement of pharmaceutical products across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 10/20/25 |